Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Allosteric inhibition explained through conformational ensembles sampling distinct "mixed" states. | Comput Struct Biotechnol J | 2020 | 33335680 | PubTator, text mining | PubMed |
| Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. | Onco Targets Ther | 2020 | 33335406 | PubTator, text mining | PubMed |
| Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma. | Front Oncol | 2020 | 33330039 | PubTator, text mining | PubMed |
| Hexokinase 2 Promotes Cell Growth and Tumor Formation Through the Raf/MEK/ERK Signaling Pathway in Cervical Cancer. | Front Oncol | 2020 | 33324557 | PubTator, text mining | PubMed |
| Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation. | Cancers (Basel) | 2020 | 33291680 | PubTator, text mining | PubMed |
| The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression. | Biomedicines | 2020 | 33287106 | PubTator, text mining | PubMed |
| Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK Signaling. | Biochemistry | 2020 | 33272017 | PubTator, text mining | PubMed |
| Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics. | Front Cardiovasc Med | 2020 | 33263009 | PubTator, text mining | PubMed |
| BRAF: A Two-Faced Janus. | Cells | 2020 | 33260892 | PubTator, text mining | PubMed |
| The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future. | Int J Mol Sci | 2020 | 33256240 | PubTator, text mining | PubMed |
| Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation. | Cancers (Basel) | 2020 | 33255818 | PubTator, text mining | PubMed |
| Epidemiologic Features of NSCLC Gene Alterations in Hispanic Patients from Puerto Rico. | Cancers (Basel) | 2020 | 33255238 | PubTator, text mining | PubMed |
| The Sensitivity and Specificity of Novel Primers for Detection of BRAFV600E Mutation. | Asian Pac J Cancer Prev | 2020 | 33247675 | PubTator, text mining | PubMed |
| The 14-3-3 Proteins as Important Allosteric Regulators of Protein Kinases. | Int J Mol Sci | 2020 | 33233473 | PubTator, text mining | PubMed |
| Severe Lymphatic Disorder Resolved With MEK Inhibition in a Patient With Noonan Syndrome and SOS1 Mutation. | Pediatrics | 2020 | 33219052 | PubTator, text mining | PubMed |
| Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. | Mol Cell | 2020 | 33217317 | PubTator, text mining | PubMed |
| Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations. | Ann Transl Med | 2020 | 33209877 | PubTator, text mining | PubMed |
| Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks. | Genes (Basel) | 2020 | 33198372 | PubTator, text mining | PubMed |
| Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer. | Front Oncol | 2020 | 33194656 | PubTator, text mining | PubMed |
| Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives. | Biomolecules | 2020 | 33182807 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=43